发明名称 |
COMBINATION ANTI-CANCER THERAPY |
摘要 |
The present invention provides a method for treating tumors or tumor metastases in a patient, comprising administering to said patient simultaneously or sequentially a therapeutically effective amount of a combination of an anti-cancer agent or treatment that elevates pAkt levels in tumor cells and an IGF-1R kinase inhibitor of Formula (I) (e.g. OSI-906). Examples of such anti-cancer agents or treatments include doxorubicin, cisplatin, and ionizing radiation. The present invention also provides a pharmaceutical composition comprising an anti-cancer agent that elevates pAkt levels in tumor cells and an IGF-1R kinase inhibitor of Formula (I), in a pharmaceutically acceptable carrier. The present invention also provides a method of identifying tumor cells that will respond most favorably to treatment with a combination of an anti-cancer agent or treatment that elevates pAkt levels in tumor cells and an IGF-1R kinase inhibitor. |
申请公布号 |
EP2173338(A1) |
申请公布日期 |
2010.04.14 |
申请号 |
EP20080779993 |
申请日期 |
2008.07.07 |
申请人 |
OSI PHARMACEUTICALS, INC. |
发明人 |
EPSTEIN, DAVID, M.;BUCK, ELIZABETH, A.;EYZAGUIRRE, ALEXANDRA;MIGLARESE, MARK, R. |
分类号 |
A61K31/352;A61K31/517;A61P35/00;G01N33/50 |
主分类号 |
A61K31/352 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|